EUVIMEDEUVIMED entdecken
FallberichtOpen Access

Radiotherapy for Metastatic Bladder Cancer in the Era of Modern Systemic Therapies

Martin E Herver Vazquez, Maria J Mora Montoya, Luis A Coria Dominguez, Erick F Granados Sanchez

Cureus · 01.08.2026

DOI: 10.7759/cureus.113796 ↗

Kurz gefasst

Fallbericht in der Zeitschrift Cureus, erschienen am 01.08.2026. Verfasst von Martin E Herver Vazquez und 3 weiteren Autor:innen. Beteiligte Einrichtung: Radiation Oncology, Centro Estatal de Cancerología "Dr. Miguel Dorantes Mesa", Xalapa, MEX. Die Arbeit nennt 18 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The management of metastatic bladder cancer is transitioning from a purely palliative model toward multimodal strategies, especially in the setting of oligometastatic disease. While systemic therapies, such as immunotherapy, have improved survival, the role of consolidative radiotherapy (RT) remains a subject of ongoing research, particularly in rare entities such as primary bladder adenocarcinoma. This review analyzes the integration of high-precision RT with modern systemic treatments to achieve durable disease control. We present the case of a male patient with stage IV bladder adenocarcinoma and synchronous brain and pulmonary metastases. Initial management involved whole-brain RT (30 Gy in 10 fractions) because of the intracranial tumor burden, followed by systemic immunotherapy with pembrolizumab. After achieving systemic stability and transitioning to an oligopersistent state, the patient received radical consolidative RT to the primary bladder tumor (50.4 Gy in 28 fractions). Subsequent consolidative surgical resection was performed, with histopathology confirming a complete pathologic response (ypT0N0). At the latest follow-up, the patient remains asymptomatic, with no evidence of active systemic disease while continuing maintenance immunotherapy. This case illustrates that a sequential, radical approach integrating RT, immunotherapy, and surgery is feasible and can lead to prolonged survival in selected patients with metastatic bladder adenocarcinoma. The shift toward consolidative local therapies in the era of modern systemic treatments represents a significant paradigm change, suggesting that RT is no longer limited to palliation but is a vital tool for achieving long-term oncologic control.

Schlagwörter

Stichwörter der Autor:innen

bladder adenocarcinomacase reviewconsolidative radiotherapyimmunotherapyoligo-metastasisoligometastatic disease

Autor:innen und Institutionen

  • Radiation Oncology, Centro Estatal de Cancerología "Dr. Miguel Dorantes Mesa", Xalapa, MEX.
  • Radiation Oncology, Universidad Veracruzana, Xalapa, MEX.
  • Medical Physics, Centro Estatal de Cancerología "Dr. Miguel Dorantes Mesa", Xalapa, MEX.

Zitieren

APA

Herver Vazquez, M. E., Mora Montoya, M. J., Coria Dominguez, L. A., & Granados Sanchez, E. F. (2026). Radiotherapy for Metastatic Bladder Cancer in the Era of Modern Systemic Therapies. Cureus. https://doi.org/10.7759/cureus.113796

Vancouver

Herver Vazquez ME, Mora Montoya MJ, Coria Dominguez LA, Granados Sanchez EF. Radiotherapy for Metastatic Bladder Cancer in the Era of Modern Systemic Therapies. Cureus. 2026. doi:10.7759/cureus.113796

BibTeX
@article{HerverVazquez2026,
  author = {Herver Vazquez, Martin E and Mora Montoya, Maria J and Coria Dominguez, Luis A and Granados Sanchez, Erick F},
  title = {Radiotherapy for Metastatic Bladder Cancer in the Era of Modern Systemic Therapies},
  journal = {Cureus},
  year = {2026},
  doi = {10.7759/cureus.113796}
}
Kostenlos starten →